Somatotropin biobetter - Ahn-Gook Pharma

Drug Profile

Somatotropin biobetter - Ahn-Gook Pharma

Alternative Names: AG B1512

Latest Information Update: 04 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ahn-Gook Pharmaceutical
  • Class Biobetters; Growth hormones; Hormonal replacements
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Growth disorders

Most Recent Events

  • 01 Apr 2017 Preclinical trials in Growth disorders in South Korea (IV)
  • 01 Apr 2017 Preclinical trials in Growth disorders in South Korea before April 2017 (SC)
  • 01 Apr 2017 Pharmacodynamics and pharmacokinetics data from preclinical study in Growth disorders presented at the 99th Annual Meeting of the Endocrine Society (ENDO-2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top